PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) here has emerged as a substantial innovation in the field of biopharmaceuticals, providing promising enhancements across numerous health care and industrial applications. With its structural similarity to By natural means derived human serum albumin, OsrHSA gives a safer, much more dependable substitute for